Daniel Couriel, MD

• Chronic Myeloid Leukemia (CML)
• Bone Marrow Transplant

Dr. Couriel is an Endowed Chair recipient and is a Tenured Associate Professor in the Division of Hematology and Hematologic Malignancies, Department of Internal Medicine, at the University of Utah School of Medicine. He received his MBA in 2021 at the University of Utah Eccles School of Business. He received his M.D. degree in 1987 at the Universidad de Buenos Aires in Argentina. After fellowship training at Tufts University, NHLBI and Johns Hopkins University, he was appointed as Assistant Professor of Medicine at the University of Alabama Birmingham. In 1999 he moved to the M.D Anderson Cancer Center in the Department of Blood and Marrow Transplantation. He was promoted to Associate Professor in 2005, and in 2010 relocated to the Sarah Cannon Blood and Marrow Transplant Program in Nashville, TN where he was appointed as Director of the Allogeneic Transplant Program. In 2010 he moved to the University of Michigan Medical School where he served as Clinical Professor and Director of the Adult Blood and Marrow Transplantation Program. Dr. Couriel has a history of consistent funding and has more than 100 peer reviewed journal articles. His research interests are associated with new treatments and biomarkers for acute and chronic graft-versus-host disease. He serves on the Editorial Board of the Biology of Blood and Marrow Transplantation journal and in addition he co-chairs the GVHD subcommittee for the CIBMTR, and the Ancillary and Supportive Care committee of a NIH Consensus Project on Chronic GVHD. He is the Medical Director for the Center of Cellular Therapy and Regenerative Medicine (CTRM) at the Huntsman Cancer Institute and the Director of the Utah Blood and Marrow Transplantation Program. He currently sits on the Board of Directors with the American Society of Cellular Therapy and Transplantation (ASTCT), and the Foundation for Accreditation of Cellular Therapy (FACT).